EGFR and non-small cell lung carcinoma: evaluated the relationship between the EGFR mutation status and the SUVmax of 18F-FDG uptake by reviewing 100 patients with NSCLC (11), reporting that patients with a low SUVmax were more likely to have an EGFR mutation as compared to patients with a high SUVmax.